社论：交叉反应性免疫与2019冠状病毒病 - Suppr

Suppr

超能文献

Editorial: Cross-reactive immunity and COVID-19.

作者信息

Vojdani Aristo, Yaqinuddin Ahmed, Beretta Alberto, Reche Pedro A

机构信息

Laboratory, Immunosciences Lab., Inc., Los Angeles, CA, United States.

Administration, Cyrex Labs, LLC, Phoenix, AZ, United States.

出版信息

Front Immunol. 2024 Dec 9;15:1509379. doi: 10.3389/fimmu.2024.1509379. eCollection 2024.

DOI:10.3389/fimmu.2024.1509379

PMID:39717772

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11663734/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e6d/11663734/b1f867743553/fimmu-15-1509379-g001.jpg

相似文献

Editorial: Cross-reactive immunity and COVID-19.社论：交叉反应性免疫与2019冠状病毒病

Front Immunol. 2024 Dec 9;15:1509379. doi: 10.3389/fimmu.2024.1509379. eCollection 2024.

mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-γ and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity.信使核糖核酸疫苗诱导的严重急性呼吸综合征冠状病毒2刺突蛋白特异性γ干扰素和白细胞介素-2 T细胞反应可预测血清中和作用，并被预先存在的交叉反应性免疫短暂增强。

J Virol. 2025 Mar 18;99(3):e0168524. doi: 10.1128/jvi.01685-24. Epub 2025 Jan 31.

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses.预先存在的交叉反应性免疫对 SARS-CoV-2 感染和疫苗反应的影响。

Nat Rev Immunol. 2023 May;23(5):304-316. doi: 10.1038/s41577-022-00809-x. Epub 2022 Dec 20.

Pre-pandemic cross-reactive antibody and cellular responses against SARS-CoV-2 among female sex workers in Dakar, Senegal.塞内加尔达喀尔女性性工作者中疫情前针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的交叉反应性抗体及细胞免疫反应

Front Public Health. 2025 Jan 23;13:1522733. doi: 10.3389/fpubh.2025.1522733. eCollection 2025.

Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.常见人类病原体和疫苗对 SARS-CoV-2 的潜在交叉反应性免疫。

Front Immunol. 2020 Oct 16;11:586984. doi: 10.3389/fimmu.2020.586984. eCollection 2020.

Pre-existing immunity to SARS-CoV-2 associates with strong T cell responses induced by inactivated COVID-19 vaccines.对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的既有免疫力与灭活新冠疫苗诱导的强烈T细胞反应相关。

J Med Virol. 2023 Mar;95(3):e28642. doi: 10.1002/jmv.28642.

Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?交叉反应性免疫是否引发 COVID-19 免疫发病机制？

Front Immunol. 2020 Oct 15;11:567710. doi: 10.3389/fimmu.2020.567710. eCollection 2020.

Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization.预先存在的交叉反应性抗体反应不会显著影响新冠灭活疫苗诱导的中和作用。

Front Immunol. 2021 Nov 19;12:772511. doi: 10.3389/fimmu.2021.772511. eCollection 2021.

Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, Vietnam.在 COVID-19 大流行（2014-2019 年）之前，针对 SARS-CoV-2 和季节性冠状病毒存在交叉反应性中和活性，但对最近新出现的 SARS-CoV-2 变体的免疫力有限，越南。

Int J Infect Dis. 2024 Feb;139:109-117. doi: 10.1016/j.ijid.2023.11.008. Epub 2023 Nov 19.

The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses.普遍冠状病毒免疫的前景：针对 SARS-CoV2 和常见人类冠状病毒的相互和非相互 T 细胞反应的特征。

Front Immunol. 2023 Oct 13;14:1212203. doi: 10.3389/fimmu.2023.1212203. eCollection 2023.

本文引用的文献

Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed analysis for influenza A virus.将不同的细菌组合在疫苗配方中可增强抗病毒交叉反应性免疫的机会：对甲型流感病毒的详细分析。

Front Immunol. 2023 Aug 22;14:1235053. doi: 10.3389/fimmu.2023.1235053. eCollection 2023.

Nonspecific Effects of Infant Vaccines Make Children More Resistant to Infection.婴儿疫苗的非特异性作用使儿童对感染更具抵抗力。

Children (Basel). 2022 Nov 29;9(12):1858. doi: 10.3390/children9121858.

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses.预先存在的交叉反应性免疫对 SARS-CoV-2 感染和疫苗反应的影响。

Nat Rev Immunol. 2023 May;23(5):304-316. doi: 10.1038/s41577-022-00809-x. Epub 2022 Dec 20.

Reaction of SARS-CoV-2 antibodies with other pathogens, vaccines, and food antigens.SARS-CoV-2 抗体与其他病原体、疫苗和食物抗原的反应。

Front Immunol. 2022 Sep 23;13:1003094. doi: 10.3389/fimmu.2022.1003094. eCollection 2022.

Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants.新冠疫苗诱导的针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变体的刺突蛋白特异性免疫的持久性

Biomedicines. 2022 Apr 26;10(5):996. doi: 10.3390/biomedicines10050996.

Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria.新型冠状病毒与病原菌之间的异源免疫

Front Immunol. 2022 Jan 27;13:821595. doi: 10.3389/fimmu.2022.821595. eCollection 2022.

Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts.交叉反应性记忆 T 细胞与 COVID-19 接触者对 SARS-CoV-2 感染的保护有关。

Nat Commun. 2022 Jan 10;13(1):80. doi: 10.1038/s41467-021-27674-x.

Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response.既往针对人类普通感冒冠状病毒的体液免疫会对 SARS-CoV-2 抗体的保护性应答产生负面影响。

Cell Host Microbe. 2022 Jan 12;30(1):83-96.e4. doi: 10.1016/j.chom.2021.12.005. Epub 2021 Dec 7.

Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses.与季节性冠状病毒预先存在的免疫有关的 SARS-CoV-2 易感性增加和 COVID-19 严重程度的证据。

Cell Rep. 2021 Dec 28;37(13):110169. doi: 10.1016/j.celrep.2021.110169. Epub 2021 Dec 7.

Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel.针对人冠状病毒和人畜共患冠状病毒的异源体液免疫：直击要害。

Semin Immunol. 2021 Jun;55:101507. doi: 10.1016/j.smim.2021.101507. Epub 2021 Oct 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验